BioCentury
ARTICLE | Clinical News

Cenderitide: Phase I started

May 9, 2011 7:00 AM UTC

Nile began a single-blind, placebo-controlled, U.S. Phase I trial in about 48 patients to evaluate subcutaneous cenderitide given as a bolus or an infusion delivered via subcutaneous pump technology f...